2 completed, 2 terminated, 1 recruiting, 1 suspended. 2 Not applicable, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Stage IVA Vulvar Cancer AJCC v8: new trials by email Literature Review of Stage IVA Vulvar Cancer AJCC v8 trials Research Report on Stage IVA Vulvar Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sexual Health Counseling Intervention During Radiation Therapy in Improving Quality of Life for Women With Gynecologic Cancer Counseling, Quality-of-Life Assessment, Questionnaire Administration - Malignant Female Reproductive System Neoplasm, Stage I Cervical Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 4 | 2021-05-20 | 2024-05-09 |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery Cisplatin, External Beam Radiation Therapy, Nelfinavir - Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 25 | 2020-08-07 | 2026-05-20 |
| Paclitaxel Therapeutic Drug Monitoring in Cancer Patients Blood draws, QLQ-CIPN20 Survey, PR-CTCAE Survey - Solid Tumor, Adult, Metastatic Nonsmall Cell Lung Cancer | Suspended | Wake Forest University Health Sciences | 55 | 2019-11-11 | 2026-08-13 | |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, Durvalumab - Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive | Phase 2 | Terminated | M.D. Anderson Cancer Center | 41 | 2018-11-14 | 2024-07-09 |
| Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers Durvalumab, Laboratory Biomarker Analysis, Stereotactic Radiosurgery - Advanced Cervical Adenocarcinoma, Advanced Vaginal Carcinoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 20 | 2018-07-18 | 2023-09-13 |
| Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer Biospecimen Collection, Laboratory Biomarker Analysis - Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ | Not applicable | Terminated | M.D. Anderson Cancer Center | 409 | 2014-10-27 | 2025-07-14 |
Vulvar Neoplasms (6) · Uterine Cervical Neoplasms (5) · Vaginal Neoplasms (4) · Anal Canal Carcinoma (1) · Anus Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Penile Neoplasms (1) · Recurrence (1) · Uterine Cervical Dysplasia (1) · Uterine Neoplasms (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Genital Diseases, Female (6) · Genital Neoplasms, Female (6) · Neoplasms by Site (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Vulvar Diseases (6) · Neoplasms (5) · Uterine Cervical Diseases (5) · Uterine Diseases (5) · Uterine Neoplasms (4) · Vaginal Diseases (4) · Adnexal Diseases (1)
Disulfides (2) · Immunoglobulin G (2) · durvalumab (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Blood Specimen Collection (1) · Cisplatin (1) · Counseling (1) · MEDI0457 (1) · Nelfinavir (1) · Platinum (1) · Radiation (1) · Radiosurgery (1) · VGX-3100 (1) · rocakinogene sifuplasmid (1) · tremelimumab (1)
M.D. Anderson Cancer Center (4) · Ohio State University Comprehensive Cancer Center (1) · Wake Forest University Health Sciences (1)
United States (6)
Lilie L Lin (2) · Allison M Quick, MD (1) · Kathleen Schmeler (1) · Michael M Frumovitz (1) · Roy Strowd, MD (1)
P30CA012197 (1)